Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Chemotherapy and Imatinib in Young Adults With Acute Lymphoblastic Leukemia Ph (BCR-ABL) POSITIVE

NCT01491763 is registered in ClinicalTrials.gov with PETHEMA Foundation as lead sponsor.

NCT NCT01491763
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01491763 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Chemotherapy and Imatinib in Young Adults With Acute Lymphoblastic Leukemia Ph (BCR-ABL) POSITIVE
Lead sponsor
PETHEMA Foundation
Phase
Phase 4
Overall status
Unknown status
Start date
January 31, 2008
Completion date
December 31, 2022
Enrollment
70 (estimated)
Sites
81

Conditions

As the registry lists them; a condition with its own page is linked.

acute lymphoblastic leukemia ph positive